Hannah Jongebloed

Hannah Jongebloed’s PhD seeks to understand how to support equitable access to Australia’s new Lung Cancer Screening Program

Hannah is conducting a comprehensive body of research examining how to optimise equity and access in Australia’s National Lung Cancer Screening Program. Her research addresses a critical timing opportunity: Australia’s program launched in July 2025, and Hannah’s work is directly aligned with implementation of this program.

“Australia has a unique opportunity to support equitable access to the national Lung Cancer Screening Program. My research is about ensuring the program reaches everyone who needs it, particularly those communities that lung cancer affects most,” says Hannah.

Hannah's research uses diverse methodologies to build evidence for program refinement

International program comparisons reveal best practices and eligibility variations

Jongebloed et al. 2026

Systematic review to understand and quantify participation gaps in lung cancer screening programs

Qualitative interview study with General Practitioners explore ways to optimise engagement in the Lung Cancer Screening Program

Health economic modelling to demonstrate the impacts of broadened eligibility criteria

About Hannah

Hannah Jongebloed is a Research Fellow currently undertaking her PhD at Deakin University’s Centre for Quality and Patient Safety Research, School of Nursing and Midwifery. With extensive experience in project coordination, stakeholder engagement, and health services research, Hannah brings detailed knowledge of Australia’s lung cancer screening program and screening programs internationally.

She is also a registered psychologist with interests and experience in how to engage populations in screening programs.

Hannah also contributes across the ECORRA program, including Chair of the ECORRA Trial Advisory Committee, Investigator on the ECORRA OCP project, author on the ECORRA Series, and project manager of ECORRA Vic.

Making Screening Accessible

Hannah’s work addresses fundamental questions about who should be eligible for lung cancer screening and how to ensure equitable access. Lung cancer disproportionately affects rural populations, and socioeconomically disadvantaged communities – groups that face additional barriers to accessing preventive health services.

Her research utilises a range of methodologies including qualitative studies, systematic reviews, clinical trials and evaluations of existing cancer services, partnering across government, health services and community groups to drive change.